BRUSSELS, January 3
Belgium will buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO, a spokesman for the health ministry said in an emailed statement.
Belgium’s health minister said in early December that the government was in talks with Merck for the purchase of molnupiravir, and Belgian health authorities had advised that both molnupiravir and Paxlovid, the drug developed by Pfizer, should be purchased.
“Both talks are finalised and we will buy 10,000 of both,” Arne Brinckman, a spokesman for the Belgian health ministry told Reuters on Monday.
(The article is generated from feeds via CT, The Chenab Times staff didn’t write this news.)
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle
(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)
The Chenab Times News Desk